| abstract |
The present invention relates to a novel method for mass production of heterologous antibodies (such as human antibodies). Preferably, this result results in inactivation of IgM heavy chain expression, and optionally inactivation of Ig light chain expression, and expression of heterologous antibodies (eg, non-bovine antibodies, preferably human antibodies). This is achieved by further introduction of artificial chromosomes. |